ACAD
NASDAQ · Biotechnology
Acadia Pharmaceuticals Inc
$20.96
-0.03 (-0.14%)
Performance
1D
—
1W
—
1M
—
3M
-24.11%
6M
-0.43%
1Y
+22.50%
YTD
-20.27%
Open$20.82
Previous Close$20.99
Day High$21.07
Day Low$20.36
52W High$28.35
52W Low$13.40
Volume—
Avg Volume1.40M
Market Cap4.01B
P/E Ratio15.34
EPS$1.55
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.91
Below
SMA 200
$23.44
Below
RSI (14)
42.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
27 analysts
Price Target
-14.6% upside
Current
$20.96
$20.96
Target
$17.90
$17.90
$12.70
$17.90 avg
$23.84
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 978.99M | 997.69M | 1.03B |
| Net Income | 231.46M | 184.03M | 167.73M |
| Profit Margin | 23.6% | 18.5% | 16.3% |
| EBITDA | 238.71M | 233.49M | 233.13M |
| Free Cash Flow | — | 197.34M | 189.95M |
| Rev Growth | — | +23.8% | +10.0% |
| Debt/Equity | — | 0.73 | 0.91 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |